Zoledronic Acid Injection
Product Images NDC 68083-142

4 FDA label images from Gland Pharma Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Zoledronic Acid (NDC 68083-142). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton Zol

Carton Zol
Packaging label for Zoledronic Acid Injection 4 mg/100 mL sterile solution for intravenous infusion by Gland Pharma Limited. The label indicates a single-dose 100 mL bottle with instructions to discard unused portions and store at 25°C. The label includes the NDC 68083-142 and a barcode, along with manufacturer details from Hyderabad, India.*
FDA Label Image

Zoledronic Structure (Zoledronic 01)

Zoledronic Structure (Zoledronic 01)
Chemical structure of zoledronic acid, showing its molecular arrangement including a pyrazole ring and two phosphonic acid groups, with water of hydration. This structural diagram corresponds to the active ingredient in Zoledronic Acid injection 4 mg/100 mL by Gland Pharma Limited.*
FDA Label Image

Image 2 (Zoledronic 02)

Image 2 (Zoledronic 02)
A bar chart showing the proportion of complete responders by day 10 in pooled HCM studies comparing Zoledronic Acid Injection 4 mg (n=86) and Pamidronate 90 mg (n=99). The chart indicates higher response for Zoledronic Acid with a p-value of 0.002.*
FDA Label Image

Zoledronic Bottle Label

Zoledronic Bottle Label
Label for Zoledronic Acid Injection 4 mg/100 mL sterile solution for intravenous infusion, packaged in a 100 mL bottle. The label includes storage instructions, infusion time requirement, manufacturer information (Gland Pharma Limited, Hyderabad, India), and NDC 68083-142-01. It cautions against mixing with calcium-containing solutions and is for single-dose use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.